Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Promega Recombinant RNasin™ Ribonuclease Inhibitor
Ribonuclease inhibitors with broad-spectrum RNase inhibitory properties. Recombinant and native available. Plus version protects RNA before, during and after heating.
$222.08 - $521.85
Specifications
| Content And Storage | -30°C to -10°C |
|---|---|
| Concentration | 20 to 40 U/μL |
| For Use With (Application) | RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems |
Description
- Broad-Spectrum Inhibition of Common Eukaryotic RNases
- Native, recombinant and oxidation-resistant forms available
- Does not inhibit SP6, T7 or T3 RNA Polymerase; GoScript™ Reverse Transcriptase, AMV or M-MLV Reverse Transcriptase; or Taq DNA polymerase.
- Use in many downstream assays: Inhibits a broad spectrum of eukaryotic RNases over a wide pH range (pH 5-8)
- Maintains inhibitory activity over a wide temperature range
Specifications
| -30°C to -10°C | |
| 20 to 40 U/μL | |
| RT-PCR, protection of mRNA in cDNA synthesis reactions, in-vitro transcription/translation, Increase yield and activity of polysomes, improvement of in-vitro virus replication, improvement of RNA translation in homologous systems |
U.S. Patents 4,966,964, 5,019,556, and 5,266,687; Australian Patents 616881 and 641261, are exclusively licensed to Promega Corporation.
U.S. Patent 5,552,302, Australian Patent 646803.
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title